glycyrrhiza glabra leaf extract은 임신 중 안전한가요?
No EU Annex II/III restriction or harmonised CLP (Annex VI) reproductive CMR classification found; CIR lists the ingredient as a cosmetic ingredient (no CIR reproductive prohibition) and PubMed literature on leaf extracts shows antifungal/biological activity but no reproductive/developmental toxicity data from dermal exposure. ECHA substance info lists company CLP notifications (flammability, and some supplier REACH/registration notes) but these are not harmonised reproductive H‑codes; company self‑notifications do not justify assuming harmonised H361/H360. Topical absorption is possible for some constituents (flavonoids/glycyrrhetinic derivatives) so I assign low measurable exposure for pregnant adults. Sources: CIR ingredient page; ECHA substance infocard; PubMed leaf‑extract studies; supplier/spec sheets.
Pregnancy-safe products containing glycyrrhiza glabra leaf extract










Related ingredients
Frequently asked questions
- glycyrrhiza glabra leaf extract은 임신 중 안전한가요?
- No EU Annex II/III restriction or harmonised CLP (Annex VI) reproductive CMR classification found; CIR lists the ingredient as a cosmetic ingredient (no CIR reproductive prohibition) and PubMed literature on leaf extracts shows antifungal/biological activity but no reproductive/developmental toxicity data from dermal exposure. ECHA substance info lists company CLP notifications (flammability, and some supplier REACH/registration notes) but these are not harmonised reproductive H‑codes; company self‑notifications do not justify assuming harmonised H361/H360. Topical absorption is possible for some constituents (flavonoids/glycyrrhetinic derivatives) so I assign low measurable exposure for pregnant adults. Sources: CIR ingredient page; ECHA substance infocard; PubMed leaf‑extract studies; supplier/spec sheets.
- glycyrrhiza glabra leaf extract은 모유 수유 중 안전한가요?
- No evidence of a harmonised reproductive/lactation hazard or EU ban/restriction for cosmetic topical use. Clinical concerns around licorice/Glycyrrhiza relate to oral glycyrrhizin ingestion (systemic mineralocorticoid effects) rather than documented hazards from topical cosmetic use; however measurable systemic absorption cannot be ruled out for certain constituents so exposure is rated low but measurable. Breastfeeding guidance in herbal safety summaries cautions about oral licorice but does not provide clear evidence of harm from topical cosmetic use. Sources: CIR ingredient page; ECHA infocard; herbal safety reviews/consumer guidance.
- glycyrrhiza glabra leaf extract은 아기 피부에 안전한가요?
- No evidence of harmonised reproductive/teratogenic classification or EU cosmetic ban/restriction specific to Glycyrrhiza glabra leaf/root extracts. Dermal absorption for adults is low–but not zero; because infant skin (0–3 yr) has higher surface‑area‑to‑weight and immature barrier, I increased exposure by +1. There are no infant‑specific dermal safety studies located for this INCI; therefore the risk scoring reflects higher exposure but no direct hazard evidence. Sources: CIR ingredient page; PubMed searches (no infant dermal reproductive/developmental studies found); supplier/spec sheets noting composition variability.
- VeriMom은 glycyrrhiza glabra leaf extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 glycyrrhiza glabra leaf extract을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 glycyrrhiza glabra leaf extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.